𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetic and molecular abnormalitiesin chronic lymphocytic leukaemia

✍ Scribed by D.G. Oscier

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
946 KB
Volume
8
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gangliosides in human chronic lymphocyti
Gangliosides in human chronic lymphocytic leukaemia
✍ Nguyen Anh-Tuan; Judit Pick; JΓ‘nos Vajda; Veronika HarsΓ‘nyi; Susan R. HollΓ‘n πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 French βš– 410 KB

Gangliosides were analysed by elaborated overpressured thin-layer chromatography (OPTLC) in 6 cell samples from 5 patients with chronic lymphocytic leukaemia (CLL) of Btell origin, and 4 individual lymphocyte preparations from normal blood donors. The principal difference in the ganglioside profile

Karyotypic evolution in B-cell chronic l
Karyotypic evolution in B-cell chronic lymphocytic leukaemia
✍ David Oscier; Margaret Fitchett; Tony Herbert; Richard Lambert πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 357 KB

Sequential cytogenetic studies were performed on a minimum of two and a maximum of nine occasions (mean 3.6) on the peripheral blood leucocytes of 112 patients with B-CLL. On initial cytogenetic analysis, 58 had a normal karyotype and 64 had a clonal abnormality. Karyotypic evolution occurred in 18

T-cell CD38 expression in B-chronic lymp
T-cell CD38 expression in B-chronic lymphocytic leukaemia
✍ Nashwa Khayrat Abousamra; Manal Salah EL-Din; Emad Azmy πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 240 KB

## Abstract B‐cell chronic lymphocytic leukaemia (B‐CLL) is a heterogeneous disease with some patients having an indolent course never needs treatment, while others having rapidly progressive one requires intensive treatment. In recent decades, numerous prognostic markers, such as immunoglobulin va